Similarly, we observed increased caspase-3 activity in PC3 prostate cancer cells and MIA PaCa-2 pancreatic cancer cells in response to doxorubicin and etoposide (Supplementary Figure S2). This evidence concerns the gene CASP3 and Familial prostate cancer.